*Deal values Omnicare at $12.7 bln, including $2.3 B debt. May 21- Drugstore operator CVS Health Corp said Thursday it will spend $10.1 billion to buy Omnicare Inc, a company that supplies prescription medicines to nursing, assisted living and other healthcare facilities. They could renegotiate their supply contracts given the volume, "said FBR analyst Steven...» Read More
NBC's Steve Handelsman reports the U.S. has 25 percent of the world's prisoners; and Joseph diGenova, Former U.S. Attorney, and Matt Welch, Reason Magazine, discuss a drug policy overhaul. "The science of marijuana is very bad," says diGenova, adding "that doesn't mean we should lock people up forever who use it."
Major League Baseball is pushing back its announcement on biogenesis punishments until later in the day. Bob Nightengale, USA Today Sports, offers insight on the details of Alex Rodriquez's expected suspension.
Pro-marijuana group Marijuana Policy Project posted a video near the Indianapolis Motor Speedway, reports CNBC's Jane Wells.
CNBC's Andrea day has been tracking the story on the mom who was accused of running a massive pot growing operation. MedMen offers clients tips on growing marijuana plants. Its founder and CEO Adam Bierman, weighs in.
Sen. Chuck Grassley says IRS officials targeted political candidates for audits, and a major player in the Mexican drug trade has been caught. CNBC's Josh Lipton has tonight's headlines; and Retired General and former drug czar Barry McCaffrey, weighs in.
Mexican armed forces arrested Miguel Angel Trevino Morales, the alleged leader of the Zetas drug cartel, near the U.S. border on Monday. Retired general and former U.S. drug czar Barry McCaffrey shares his knowledge of Morales' criminal career.
The accused "pot mom" Andrea Sanderlin arrived at court alone, reports CNBC's Andrea Day. Sanderlin is accused of growing 3,000 marijuana plants with intent to distribute.
Costco Wholesale reported June same-store sales that beat analysts' estimates, while L Brands sales came in lower than expected.
Accused Boston Bomber Dzhokhar Tsarnaev pleaded not guilty to all charges, reports CNBC's Bertha Coombs.
Andrea Sanderlin was accused of running a multi-million dollar marijuana warehouse. CNBC's Mary Thompson reports the judge on the case is requiring additional guarantors before granting her bail. (*Note: She was granted bail later in the day.)
CNBC's Mary Thompson reports on the "pot mom," who was arrested in May for housing pot plants worth over $3 million. The operation allegedly funded her high-end lifestyle.
If you couldn't be Don Draper on "Mad Men," you could at least drink like him, but now vodka is back as America's favorite.
Andrea Sanderlin of Scarsdale, New York, has been indicted for manufacturing and possessing marijuana with intent to distribute. CNBC's Andrea Day has the details.
A panel of experts and Larry Kudlow discuss the Supreme Court's refusal to declare "pay to delay" deals between pharmaceutical companies and generic drugmakers illegal.
Arena Pharmaceuticals' new obesity drug Belviq hits the U.S. shelves today. Lonnel Coats, Eisai CEO, and Jack Lief, Arena CEO, discuss expectations for the drug.
Allergy season has been getting longer every year for 15 years, with Dr. Michael Foggs of American College of Allergy, Asthma and Immunology; and Stephen Brozak, WBB Securities, discusses the big money in the allergy business.
Andrea Sanderlin is not an actress, but her story—a horse-riding suburban mother of three accused of running a multimillion-dollar marijuana ring—sounds like a television show.
As Coca-Cola unveiled its first processing plant in Myanmar, one analyst warned that the move into frontier markets could mean emerging markets are not as attractive to multi-nationals as they once were.
Jamen Shively, a former Microsoft executive and currently CEO of Diego Pellicer, wants to build the first national marijuana store brand.
CNBC's Jackie DeAngelis reports on drug companies making headlines out of the American Society of Clinical Onocology conference. David Risinger of Morgan Stanley discusses the rise in melanoma treatments shown at this year's event.